Literature DB >> 15531903

Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.

H T Greinix1, I Faé, B Schneider, A Rosenmayr, A Mitterschiffthaler, B Pelzmann, P Kalhs, K Lechner, W R Mayr, G F Fischer.   

Abstract

There is consensus that matching of unrelated donors (URD) and patients for HLA class II alleles improves the outcome of hematopoietic stem cell transplantation (HSCT). However, the significance of HLA class I allelic mismatches for transplant outcome is under discussion and reports on long-term effects like chronic graft-versus-host disease (GVHD) are rare. Thus, we investigated the association of human leukocyte antigen (HLA) class I allele mismatches and outcome in 144 patients given HSCT from URD who were matched for HLA-DRB1, DRB3/4/5, and DQB1 alleles. The risk of chronic GVHD was significantly increased in patients with class I mismatched donors, the mismatch either detected by low- or high-resolution typing. A single HLA class I allele mismatch significantly increased the risk of chronic GVHD in multivariate analysis. Overall survival was significantly reduced in patient/donor pairs with more than one-allele class I mismatch. Thus, selection of unrelated donors for transplantation should be based on high-resolution HLA class I typing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15531903     DOI: 10.1038/sj.bmt.1704741

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  17 in total

1.  Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

Authors:  Joseph Pidala; Tao Wang; Michael Haagenson; Stephen R Spellman; Medhat Askar; Minoo Battiwalla; Lee Ann Baxter-Lowe; Menachem Bitan; Marcelo Fernandez-Viña; Manish Gandhi; Ann A Jakubowski; Martin Maiers; Susana R Marino; Steven G E Marsh; Machteld Oudshoorn; Jeanne Palmer; Vinod K Prasad; Vijay Reddy; Olle Ringden; Wael Saber; Stella Santarone; Kirk R Schultz; Michelle Setterholm; Elizabeth Trachtenberg; E Victoria Turner; Ann E Woolfrey; Stephanie J Lee; Claudio Anasetti
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

Review 2.  Biomarkers in chronic graft-versus-host disease.

Authors:  Jacob Rozmus; Kirk R Schultz
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

3.  Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation.

Authors:  A Rockstroh; H K Al-Ali; T Lange; W Pönisch; R Krahl; M Cross; G Behre; D Niederwieser; C Pfrepper
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-01       Impact factor: 4.553

4.  A multi-site study using high-resolution HLA genotyping by next generation sequencing.

Authors:  C L Holcomb; B Höglund; M W Anderson; L A Blake; I Böhme; M Egholm; D Ferriola; C Gabriel; S E Gelber; D Goodridge; S Hawbecker; R Klein; M Ladner; C Lind; D Monos; M J Pando; J Pröll; D C Sayer; G Schmitz-Agheguian; B B Simen; B Thiele; E A Trachtenberg; D B Tyan; R Wassmuth; S White; H A Erlich
Journal:  Tissue Antigens       Date:  2011-03

5.  Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.

Authors:  Hirohisa Nakamae; Barry E Storer; Rainer Storb; Jan Storek; Thomas R Chauncey; Michael A Pulsipher; Finn B Petersen; James C Wade; Michael B Maris; Benedetto Bruno; Jens Panse; Effie Petersdorf; Ann Woolfrey; David G Maloney; Brenda M Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-10       Impact factor: 5.742

6.  Should all unrelated donors for transplantation be matched?

Authors:  Daniel Weisdorf
Journal:  Best Pract Res Clin Haematol       Date:  2008-03       Impact factor: 3.020

Review 7.  Biologic markers of chronic GVHD.

Authors:  J Pidala; M Sarwal; S Roedder; S J Lee
Journal:  Bone Marrow Transplant       Date:  2013-07-22       Impact factor: 5.483

8.  High-resolution, high-throughput HLA genotyping by next-generation sequencing.

Authors:  G Bentley; R Higuchi; B Hoglund; D Goodridge; D Sayer; E A Trachtenberg; H A Erlich
Journal:  Tissue Antigens       Date:  2009-11

9.  HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

Authors:  Mukta Arora; Daniel J Weisdorf; Stephen R Spellman; Michael D Haagenson; John P Klein; Carolyn K Hurley; George B Selby; Joseph H Antin; Nancy A Kernan; Craig Kollman; Auayporn Nademanee; Philip McGlave; Mary M Horowitz; Effie W Petersdorf
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

10.  Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Stephanie J Lee; Kwang Woo Ahn; Stephen Spellman; Hai-Lin Wang; Mahmoud Aljurf; Medhat Askar; Jason Dehn; Marcelo Fernandez Viña; Alois Gratwohl; Vikas Gupta; Rabi Hanna; Mary M Horowitz; Carolyn K Hurley; Yoshihiro Inamoto; Adetola A Kassim; Taiga Nishihori; Carlheinz Mueller; Machteld Oudshoorn; Effie W Petersdorf; Vinod Prasad; James Robinson; Wael Saber; Kirk R Schultz; Bronwen Shaw; Jan Storek; William A Wood; Ann E Woolfrey; Claudio Anasetti
Journal:  Blood       Date:  2014-08-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.